10-Q Filing

ALIGNMENT HEALTHCARE, INC. CIK: 1832466 Q3 2024

Filing Information

Form Type	10-Q
Accession Number	`0001628280-24-044092`
Period End Date	20240930
Filing Date	20241029
Fiscal Year	2024
Fiscal Period	Q3
XBRL Instance	alhc-20240930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 154 Income Statement 160 Cash Flow Statement 166 Stockholders Equity 56

Balance Sheet 154 line items

Line Item	Tag	Value	Unit	Period
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$123.00K	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$123.00K	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$391.64M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$391.64M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$340.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$340.30M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$202.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$202.90M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $123 at September 30, 2024 and $0 at December 31, 2023)	`AccountsReceivableNetCurrent`	$119.75M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $123 at September 30, 2024 and $0 at December 31, 2023)	`AccountsReceivableNetCurrent`	$119.75M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable (less allowance for credit losses of $123 at September 30, 2024 and $0 at December 31, 2023)	`AccountsReceivableNetCurrent`	$138.85M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $123 at September 30, 2024 and $0 at December 31, 2023)	`AccountsReceivableNetCurrent`	$138.85M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Investments - current	`ShortTermInvestments`	$40.68M	USD	Point-in-time
Investments - current	`ShortTermInvestments`	$40.68M	USD	Point-in-time
Investments - current	`ShortTermInvestments`	$115.91M	USD	Point-in-time
Investments - current	`ShortTermInvestments`	$115.91M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$53.78M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$53.78M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$44.97M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$44.97M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$573.61M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$573.61M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$483.54M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$483.54M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$51.90M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$51.90M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	188.95M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	188.95M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$64.69M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$64.69M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$8.12M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$8.12M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$9.96M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$9.96M	USD	Point-in-time
Goodwill, Net	`Goodwill`	$34.83M	USD	Point-in-time
Goodwill, Net	`Goodwill`	$34.83M	USD	Point-in-time
Goodwill, Net	`Goodwill`	$34.83M	USD	Point-in-time
Goodwill, Net	`Goodwill`	$34.83M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.55M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.55M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.25M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.25M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.41M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.41M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.49M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.49M	USD	Point-in-time
Total assets	`Assets`	$591.88M	USD	Point-in-time
Total assets	`Assets`	$591.88M	USD	Point-in-time
Total assets	`Assets`	$692.29M	USD	Point-in-time
Total assets	`Assets`	$692.29M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$297.12M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$297.12M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$205.40M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$205.40M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$25.39M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$25.39M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$23.51M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$23.51M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$33.95M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$33.95M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$34.11M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$34.11M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtCurrent`	-	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtCurrent`	-	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtCurrent`	$1.61M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtCurrent`	$1.61M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$263.02M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$263.02M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$358.08M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$358.08M	USD	Point-in-time
Long-term debt, net of current maturities and debt issuance costs	`LongTermDebtNoncurrent`	$210.39M	USD	Point-in-time
Long-term debt, net of current maturities and debt issuance costs	`LongTermDebtNoncurrent`	$210.39M	USD	Point-in-time
Long-term debt, net of current maturities and debt issuance costs	`LongTermDebtNoncurrent`	$161.81M	USD	Point-in-time
Long-term debt, net of current maturities and debt issuance costs	`LongTermDebtNoncurrent`	$161.81M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$8.97M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$8.97M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$8.19M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$8.19M	USD	Point-in-time
Total liabilities	`Liabilities`	$576.66M	USD	Point-in-time
Total liabilities	`Liabilities`	$576.66M	USD	Point-in-time
Total liabilities	`Liabilities`	$433.81M	USD	Point-in-time
Total liabilities	`Liabilities`	$433.81M	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of September 30, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of September 30, 2024 and December 31, 2023	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of September 30, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of September 30, 2024 and December 31, 2023	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of September 30, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of September 30, 2024 and December 31, 2023	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of September 30, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of September 30, 2024 and December 31, 2023	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 191,595,786 and 188,951,643 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$189.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 191,595,786 and 188,951,643 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$189.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 191,595,786 and 188,951,643 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$191.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 191,595,786 and 188,951,643 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$191.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.04B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.04B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.09B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.09B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-977.20M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-977.20M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-880.26M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-880.26M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$114.55M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$114.55M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$156.95M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$156.95M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.08M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.08M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.12M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.12M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$211.11M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$211.11M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$189.60M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$189.60M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$115.63M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$115.63M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$591.88M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$591.88M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$692.29M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$692.29M	USD	Point-in-time

Income Statement 160 line items

Line Item	Tag	Value	Unit	Period
Earned premiums	`PremiumsEarnedNet`	$684.50M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$684.50M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$1.34B	USD	3 Qtrs
Earned premiums	`PremiumsEarnedNet`	$1.34B	USD	3 Qtrs
Earned premiums	`PremiumsEarnedNet`	$1.98B	USD	3 Qtrs
Earned premiums	`PremiumsEarnedNet`	$1.98B	USD	3 Qtrs
Earned premiums	`PremiumsEarnedNet`	$450.24M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$450.24M	USD	1 Quarter
Other	`OtherIncome`	$7.94M	USD	1 Quarter
Other	`OtherIncome`	$7.94M	USD	1 Quarter
Other	`OtherIncome`	$6.47M	USD	1 Quarter
Other	`OtherIncome`	$6.47M	USD	1 Quarter
Other	`OtherIncome`	$22.17M	USD	3 Qtrs
Other	`OtherIncome`	$22.17M	USD	3 Qtrs
Other	`OtherIncome`	$16.32M	USD	3 Qtrs
Other	`OtherIncome`	$16.32M	USD	3 Qtrs
Total revenues	`Revenues`	$456.71M	USD	1 Quarter
Total revenues	`Revenues`	$456.71M	USD	1 Quarter
Total revenues	`Revenues`	$692.43M	USD	1 Quarter
Total revenues	`Revenues`	$692.43M	USD	1 Quarter
Total revenues	`Revenues`	$1.36B	USD	3 Qtrs
Total revenues	`Revenues`	$1.36B	USD	3 Qtrs
Total revenues	`Revenues`	$2.00B	USD	3 Qtrs
Total revenues	`Revenues`	$2.00B	USD	3 Qtrs
Medical expenses	`MedicalExpenses`	$397.88M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$397.88M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$613.44M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$613.44M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$1.79B	USD	3 Qtrs
Medical expenses	`MedicalExpenses`	$1.79B	USD	3 Qtrs
Medical expenses	`MedicalExpenses`	$1.20B	USD	3 Qtrs
Medical expenses	`MedicalExpenses`	$1.20B	USD	3 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$90.87M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$90.87M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$269.25M	USD	3 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$269.25M	USD	3 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$83.09M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$83.09M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$223.70M	USD	3 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$223.70M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$5.50M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$5.50M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$20.11M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$20.11M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$7.64M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$7.64M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$15.61M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$15.61M	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$711.96M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$711.96M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$486.46M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$486.46M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$1.44B	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$1.44B	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$2.08B	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$2.08B	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-79.01M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-79.01M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-85.90M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-85.90M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-29.76M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-29.76M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-19.52M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-19.52M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$15.75M	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$15.75M	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$18.05M	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$18.05M	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$6.94M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$6.94M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$5.47M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$5.47M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$711.00K	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$711.00K	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$22.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$22.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$145.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$145.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$72.00K	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$72.00K	USD	3 Qtrs
Total other expenses	`NonoperatingIncomeExpense`	$-5.32M	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-5.32M	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-17.98M	USD	3 Qtrs
Total other expenses	`NonoperatingIncomeExpense`	$-17.98M	USD	3 Qtrs
Total other expenses	`NonoperatingIncomeExpense`	$-6.92M	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-6.92M	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-15.04M	USD	3 Qtrs
Total other expenses	`NonoperatingIncomeExpense`	$-15.04M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-35.08M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-35.08M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-100.94M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-100.94M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-26.44M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-26.44M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-96.99M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-96.99M	USD	3 Qtrs
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	$-8.00K	USD	1 Quarter
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	$-8.00K	USD	1 Quarter
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	$14.00K	USD	3 Qtrs
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	$14.00K	USD	3 Qtrs
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	$2.00K	USD	3 Qtrs
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	$2.00K	USD	3 Qtrs
Net loss	`ProfitLoss`	$-97.01M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-97.01M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-35.08M	USD	1 Quarter
Net loss	`ProfitLoss`	$-35.08M	USD	1 Quarter
Net loss	`ProfitLoss`	$-100.94M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-100.94M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-26.43M	USD	1 Quarter
Net loss	`ProfitLoss`	$-26.43M	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-63.00K	USD	3 Qtrs
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-63.00K	USD	3 Qtrs
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-30.00K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-30.00K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-16.00K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-16.00K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-134.00K	USD	3 Qtrs
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-134.00K	USD	3 Qtrs
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-35.05M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-35.05M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-26.41M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-26.41M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-100.81M	USD	3 Qtrs
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-100.81M	USD	3 Qtrs
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-96.94M	USD	3 Qtrs
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-96.94M	USD	3 Qtrs
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	190.42M	shares	3 Qtrs
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	190.42M	shares	3 Qtrs
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	185.49M	shares	3 Qtrs
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	185.49M	shares	3 Qtrs
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	187.33M	shares	1 Quarter
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	187.33M	shares	1 Quarter
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	191.36M	shares	1 Quarter
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	191.36M	shares	1 Quarter
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	190.42M	shares	3 Qtrs
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	190.42M	shares	3 Qtrs
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	185.49M	shares	3 Qtrs
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	185.49M	shares	3 Qtrs
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	187.33M	shares	1 Quarter
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	187.33M	shares	1 Quarter
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	191.36M	shares	1 Quarter
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	191.36M	shares	1 Quarter
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.19	USD	1 Quarter
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.19	USD	1 Quarter
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.51	USD	3 Qtrs
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.51	USD	3 Qtrs
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.54	USD	3 Qtrs
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.54	USD	3 Qtrs
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.14	USD	1 Quarter
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.14	USD	1 Quarter
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.51	USD	3 Qtrs
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.51	USD	3 Qtrs
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.54	USD	3 Qtrs
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.54	USD	3 Qtrs
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.19	USD	1 Quarter
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.19	USD	1 Quarter
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.14	USD	1 Quarter
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.14	USD	1 Quarter

Cash Flow Statement 166 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-97.01M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-97.01M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-35.08M	USD	1 Quarter
Net loss	`ProfitLoss`	$-35.08M	USD	1 Quarter
Net loss	`ProfitLoss`	$-100.94M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-100.94M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-26.43M	USD	1 Quarter
Net loss	`ProfitLoss`	$-26.43M	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$28.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$28.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$40.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$40.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$91.00K	USD	3 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$91.00K	USD	3 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$123.00K	USD	3 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$123.00K	USD	3 Qtrs
Loss (gain) on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	$-135.00K	USD	3 Qtrs
Loss (gain) on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	$-135.00K	USD	3 Qtrs
Loss (gain) on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	$289.00K	USD	3 Qtrs
Loss (gain) on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	$289.00K	USD	3 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	3 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	3 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$8.00K	USD	3 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$8.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$20.25M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$20.25M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$15.81M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$15.81M	USD	3 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$2.08M	USD	3 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$2.08M	USD	3 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$3.35M	USD	3 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$3.35M	USD	3 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$978.00K	USD	3 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$978.00K	USD	3 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$1.04M	USD	3 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$1.04M	USD	3 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$51.18M	USD	3 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$51.18M	USD	3 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$54.90M	USD	3 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$54.90M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$1.65M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$1.65M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$1.36M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$1.36M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$19.23M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$19.23M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$12.72M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$12.72M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.77M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.77M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$8.81M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$8.81M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$119.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$119.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-77.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-77.00K	USD	3 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$33.30M	USD	3 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$33.30M	USD	3 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$91.73M	USD	3 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$91.73M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$2.83M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$2.83M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-4.61M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-4.61M	USD	3 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$146.03M	USD	3 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$146.03M	USD	3 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-116.00K	USD	3 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-116.00K	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$-161.00K	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$-161.00K	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$7.60M	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$7.60M	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-2.62M	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-2.62M	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.49M	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.49M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$43.48M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$43.48M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$128.28M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$128.28M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$281.58M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$281.58M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$75.52M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$75.52M	USD	3 Qtrs
Sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$14.00K	USD	3 Qtrs
Sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$14.00K	USD	3 Qtrs
Sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	3 Qtrs
Sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	3 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$160.74M	USD	3 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$160.74M	USD	3 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$152.75M	USD	3 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$152.75M	USD	3 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$25.40M	USD	3 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$25.40M	USD	3 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$32.13M	USD	3 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$32.13M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-146.25M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-146.25M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$45.11M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$45.11M	USD	3 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$50.00M	USD	3 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$50.00M	USD	3 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	3 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$512.00K	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$512.00K	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	3 Qtrs
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	3 Qtrs
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	3 Qtrs
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	3 Qtrs
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	3 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$60.00K	USD	3 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$60.00K	USD	3 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$15.00K	USD	3 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$15.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$49.15M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$49.15M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$60.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$60.00K	USD	3 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$137.75M	USD	3 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$137.75M	USD	3 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-17.91M	USD	3 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-17.91M	USD	3 Qtrs
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$342.70M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$342.70M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$393.39M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$393.39M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$342.70M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$342.70M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$393.39M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$393.39M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$15.60M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$15.60M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$13.94M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$13.94M	USD	3 Qtrs
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$117.00K	USD	3 Qtrs
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$117.00K	USD	3 Qtrs
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$112.00K	USD	3 Qtrs
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$112.00K	USD	3 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$391.64M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$391.64M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$340.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$340.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$202.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$202.90M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$1.75M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$1.75M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.40M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.40M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$342.70M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$342.70M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$393.39M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$393.39M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time

Stockholders Equity 56 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$211.11M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$211.11M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$189.60M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$189.60M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$115.63M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$115.63M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Net loss	`ProfitLoss`	$-97.01M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-97.01M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-35.08M	USD	1 Quarter
Net loss	`ProfitLoss`	$-35.08M	USD	1 Quarter
Net loss	`ProfitLoss`	$-100.94M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-100.94M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-26.43M	USD	1 Quarter
Net loss	`ProfitLoss`	$-26.43M	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$2.00K	USD	3 Qtrs
Issuance of common stock upon vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$2.00K	USD	3 Qtrs
Issuance of common stock upon vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$2.00K	USD	3 Qtrs
Issuance of common stock upon vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$2.00K	USD	3 Qtrs
Issuance of common stock upon vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$1.00K	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$1.00K	USD	1 Quarter
Shares withheld related to net restricted stock settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	3 Qtrs
Shares withheld related to net restricted stock settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	3 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$17.26M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$17.26M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$54.90M	USD	3 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$54.90M	USD	3 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$13.57M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$13.57M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$51.18M	USD	3 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$51.18M	USD	3 Qtrs
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$15.00K	USD	3 Qtrs
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$15.00K	USD	3 Qtrs
Repurchase of noncontrolling interest attributable to subsidiary	`MinorityInterestDecreaseFromRedemptions`	$-60.00K	USD	3 Qtrs
Repurchase of noncontrolling interest attributable to subsidiary	`MinorityInterestDecreaseFromRedemptions`	$-60.00K	USD	3 Qtrs
Ending Balance (in shares)	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$211.11M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$211.11M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$189.60M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$189.60M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$115.63M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$115.63M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.